| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3934513 | Fertility and Sterility | 2014 | 8 Pages | 
Abstract
												Antimüllerian hormone is a fairly robust metric for the prediction of cancellation and how many oocytes may be retrieved after stimulation but is a relatively poor test for prediction of pregnancy after any given treatment cycle. Patients with extremely low levels of AMH still can achieve reasonable treatment outcomes and should not be precluded from attempting IVF solely on the basis of an AMH value.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												David E. M.D., Dan M.D., Zev M.D., 
											